Search Results for “study of the week” – Page 119

Understanding Pregnancy and COVID-19

At the start of 2020, we had no idea what this year would bring: COVID-19, a novel coronavirus declared a pandemic in March. As of the morning of July 17,…

Rilonacept Receives Orphan Drug Designation for Pericarditis Treatment

This past week, biopharmaceutical company Kiniksa Pharmaceuticals announced that their drug, rilonacept, received Orphan Drug Designation from the FDA. Following positive data from the RHAPSODY Phase 3 clinical trial,…

Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

According to a story from Physician's Weekly, while measuring the concentration of albumin (albuminuria) is widely considered the standard method for staging and screening for chronic kidney disease, a different…

First Patient Enrolls in BOLD Trial for Biliary Atresia

According to a recent press release from Albireo Pharma, the first participant has enrolled in the BOLD trial. The BOLD trial, which stands for Biliary atresia and the use…

Remdesivir Showed 74.4% Recovery for COVID-19 Within Fourteen Days of Hospitalization

While the world is waiting for a vaccine to prevent, mitigate, or cure COVID-19, the investigational drug remdesivir continues to show promise. The FDA recently gave it Emergency Use…

Early COVID-19 Vaccine Tests Show Some Potential

According to a story from Buzzfeed News, a recent test of an experimental COVID-19 vaccine being developed by Moderna Therapeutics demonstrated that it was able to produce antibodies in all…

ICYMI: Studies Compare Procedures for Reducing Risk of Heart Attacks

The National Institutes of Health (NIH) recently published the results of studies based on a controversy that has remained unresolved for decades. The ISCHEMIA study is not only the…

NAFLD Risk and Progression in Men Versus Women

By Lauren Thayer from In The Cloud Copy Nonalcoholic fatty liver disease or NAFLD is a term used to describe a range of conditions in which a patient’s liver has…